Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 9, 2003, Pages 1595-1600

  Proctor, Spencer D ^b   Mamo, John C L ^a  

^a CURTIN UNIVERSITY   (Australia)

^b NONE

Author keywords

Apolipoprotein B100; Apolipoprotein B48; Arterial retention; LDL; Postprandial lipoproteins

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHYLOMICRON; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CHOLESTEROL METABOLISM; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RABBIT;

ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; CAROTID ARTERIES; CHOLESTEROL; DISEASE MODELS, ANIMAL; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS; RABBITS; TUNICA INTIMA;

EID: 0042691798     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000084638.14534.0A     Document Type: Article

References (42)

1. Bjornheden T, Bondjers G, Wiklund O. Direct assessment of lipoprotein outflow from in vivo-labelled arterial tissue as determined in an in vitro perfusion system. Arterioscler Thromb Vasc Biol. 1998;18:1927-1933.
2. Nielsen LB. Transfer of low density lipoproteins into the arterial wall and risk of atherosclerosis. Atherosclerosis. 1996;123:1-15.
3. Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol-fed rabbits, II: selective retention of LDL vs selective increases in LDL permeability in susceptible sites of arteries Arteriosclerosis. 1989;9:908-918.
4. Simionescu N, Simionescu M. Cellular interactions of lipoproteins with the vascular endothelium: endocytosis and transcytosis. Targital Diagn Ther. 1991;5:45-97.
5. Nordestgaard BG, Tybjaerg-Hansen A. IDL, VLDL and chylomicrons and atherosclerosis. Eur J Epidemiol. 1992;8:92-98.
6. Steinberg D, Pittman RC, Carew TE. Mechanisms involved in the uptake and degradation of low density lipoproteins by the artery wall in vivo. Ann N Y Acad Sci. 1985;454:195-207.
7. Romanov YA, Balyasnikova IV, Bystrevskaya VB, Byzoya TV, Ilyinskaya OP, Krushinsky AV, Latsis RV, Soboleva EL, Tararak EM, Smirinov VN. Endothelial heterogeneity and intimal blood-borne cells: relation to human atherosclerosis. Ann N Y Acad Sci. 1995;748:12-37.
8. Nicoll A, Duffield R, Lewis B. Flux of plasma lipoproteins into human arterial intima. Atherosclerosis. 1981;39:229-242.
9. Proctor SD, Mamo JCL. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall: evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur J Clin Invest. 1998;28:497-503.
10. Proctor SD, Vine DF, Mamo JCL. Arterial retention of apolipoproteinB48 and B100-containing lipoproteins in atherogenesis. Curr Opin Lipidol. 2002;5:461-470.
11. Nordestgaard BG, Zilversmit DB. Comparison of arterial intimal clearances of LDL form diabetic and non-diabetic cholesterol-fed rabbits: differences in intimal clearance explained by size differences. Arteriosclerosis. 1989;9:176-183.
12. Nordestgaard BG, Stender S, Kjeldsen K. Reduced atherogenesis in cholesterol-fed diabetic rabbits: giant lipoproteins do not enter the arterial wall. Arteriosclerosis. 1988;8:421-428.
13. Proctor SD, Mamo JCL. Arterial fatty lesions have increased uptake of chylomicron-remnants but not low-density lipoproteins. Coron Artery Dis. 1997;7:239-245.
14. Mamo JCL, Wheeler JR. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein and albumin. Coron Artery Dis. 1994;5:695-705.
15. Karpe F, Tornvall P, Olivecrona T, Steiner G, Calson LA, Hamsten A. Composition of human low-density lipoprotein: effects of postprandial triglyceride rich lipoproteins, lipoproteins lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis. 1993;98:33-49.
16. Krauss RM. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol. 1994;38:339-349.
17. Pal S, Semorine K, Watts GF, Mamo JC. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin Chem Lab Med. In press.
18. Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G. Association of apoB lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis. 1998;139:205-222.
19. Friedman MH, Fry DL. Arterial permeability dynamics and vascular disease. Atherosclerosis. 1993;104:189-194.
20. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, Liron M, Rubinstein A, Iaina A. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. Brit Med J. 1996;312:935-939.
21. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, Havekes L. Postprandial lipoprotein metabolism in normolipidaemic men with and without coronary artery disease. Arterioscler Thromb. 1991;11:653-662.
22. Bowler A, Redgrave TG, Mamo JCL. Chylomicron remnant clearance in homozygote and heterozygote Watanabe heritable hyperlipidemic rabbits is defective: lack of evidence for an independent chylomicron-remnant receptor. Biochem J. 1991;276:381-386.
23. Yu K, Mamo JCL. Binding and uptake of chylomicron remnants by cultured arterial smooth muscle cells from normal and Watanabe heritable hyperlipidemic rabbits. Biochim Biophys Acta 1997;1346:212-220.
24. Smith D, Proctor SD, Mamo JCL. A highly sensitive assay for quantitation of apolipoprotein B48 using an antibody to human apolipoprotein B and enhanced chemo-luminescence. Ann Clin Biochem. 1997;34:185-189.
25. Yu KC, Cooper AD. Post-prandial lipoproteins and atherosclerosis. Front Biosci. 2001;6:D332-D354.
26. Choi SY, Cooper AD. A comparison of the roles of the low density lipoprotein (LDL) receptor and the LDL receptor-related protein/alpha 2-macroglobulin receptor in chylomicron-remnant removal in the mouse in-vivo. J Biol Chem. 1993;268:15804-15811.
27. Oorni K, Hakala JK, Annila A, Ala-Korpela M, Kovanen PT. Sphingo-myelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles: two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J Biol Chem. 1998;273:29127-19134.
28. Olsson U, Camejo G, Bondgers G. Binding of a synthetic apolipoprgtein B100 peptide and peptide analogues to chondrotitin 6-sulfate: effects of the lipid environment. Biochemistry. 1993;32:1858-1865.
29. Chauhan V, Wang X, Ramsamy T, Milne RW, Sparks DL. Evidence for lipid-dependent structural changes in specific domains of apolipoprotein B100. Biochemistry. 1998;37:3735-3742.
30. Kleinman Y, Krul ES, Burnes M, Aronson W, Pfleger B, Schonfeld G. Lipolysis of LDL with phospholipase A2 alters the expression of selected apo B100 epitopes and the interaction of LDL with cells. J Lipid Res. 1988;29:729-743.
31. McNamara JR, Small DM, Li Z, Schaefer EJ. Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B. J Lipid Res. 1996;37:1924-1935.
32. Sartipy P, Camejo G, Svensson L, Hurt-Camejo E. Phospholipase A2 modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans. J Biol Chem. 1999;274:25913-25920.
33. Millar JS. The sialylation of plasma lipoproteins. Atherosclerosis. 2001;154:1-13.
34. Deleted in proof.
35. Camejo G, Lopez A, Lopez F, Quinones J. Interaction of low density lipoproteins with arterial proteoglycans: the role of charge and sialic acid content. Atherosclerosis. 1985;55:93-105.
36. Millar JS, Anber V, Shepherd J, Packard CJ. Sialic acid containing components of lipoproteins influence lipoprotein proteoglycan interactions. Atherosclerosis. 1999;145:253-260.
37. Anber V, Millar JS, McConnell M, Shepherd J, Packard CJ. Interaction of very low density, intermediate density, and low density lipoproteins with human arterial wall proteoglycans. Arterioscler Thromb Vasc Biol. 1997;17:2507-2514.
38. Tozer EC, Carew TE. Residence time of low-density lipoprotein in the normal and atherosclerotic rabbit aorta. Circ Res. 1997;80:208-218.
39. Rosenfeld ME, Carew TE, von Hodenberg E, Pittmen RC, Ross R, Steinberg D. Autoradiographical analysis of the distribution of 1251-tyramine-cellobiose-LDL in atherosclerotic lesions of the WHHL rabbit. Arterioscler Thromb. 1992;12:985-995.
40. Nievelstein PF, Fogelman Am, Mottino G, Frank JS. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low-density lipoprotein: a deep-etch and immunolocalization study of ultra-rapidly frozen tissue. Arterioscler Thromb. 1991;11:1795-1805.
41. Schwenke DC, St Clair RW. Influx, efflux and accumulation of LDL in normal arterial areas and atherosclerotic lesions of white Carneau pigeons with naturally occurring and cholesterol-aggravated aortic atherosclerosis. Arterioscler Thromb. 1993;13:1368-1381.
42. Camejo G, Hurt-Camejo E, Olsson U, Bondjers G. Lipid mediators that modulate the extracellular matrix structure and function in vascular cells. Curr Atheroscler Rep. 1999;1:142-149.